Ftse Mib
34.704,40
0,61%
DAX
18.608,16
0,68%
S&P 500
5.244,84
-0,62%
NASDAQ
16.683,97
-0,30%
Bitcoin
68.960,88
1,79%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Vir Biotechnology Inc (VIR) Vir Biotechnology Inc (VIR) Notizie

Vir Biotechnology Inc

VIR
10,68
0,41 (3,99%)
Ultimo aggiornamento: 18:51:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/6/202418:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202417:57EDGAR2Form 3 - Initial statement of beneficial ownership of..
31/5/202420:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202420:42EDGAR2Form 3 - Initial statement of beneficial ownership of..
29/5/202422:06EDGAR2Form 8-K - Current report
29/5/202422:05BWVir Biotechnology to Participate in the Goldman Sachs 45th..
29/5/202414:05BWVir Biotechnology Appoints Mark Eisner, M.D., M.P.H. as..
23/5/202422:05BWVir Biotechnology to Host 2024 Annual Meeting of..
22/5/202414:05BWMultiple Abstracts Highlighting Vir Biotechnology’s Latest..
21/5/202414:17BWVir Biotechnology Announces SOLSTICE Data to be Featured as..
14/5/202422:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
02/5/202422:05BWVir Biotechnology Provides Corporate Update and Reports..
30/4/202422:05BWVir Biotechnology to Participate in the BofA Securities..
18/4/202414:00BWVir Biotechnology Announces Nomination of Norbert..
11/4/202422:30BWVir Biotechnology to Provide Business Update and Report..
05/3/202414:05BWVir Biotechnology Completes Enrollment of Phase 2 Chronic..
27/2/202401:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202401:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202401:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202401:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:27EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/2/202422:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
23/2/202414:05BWVir Biotechnology to Participate in Upcoming Investor..
22/2/202422:12EDGAR2Form 8-K - Current report
22/2/202422:05BWVir Biotechnology Provides Corporate Update and Reports..
20/2/202422:33EDGAR2Form 8-K - Current report
20/2/202422:30BWVir Biotechnology Announces Dr. Phil Pang Will Step Down as..
17/2/202400:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202423:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202422:05BWVir Biotechnology to Provide Business Update and Report..
03/1/202420:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202311:59IHMARKETNEWSApple Stocks Reach Record, Adobe Faces Stock Drops,..
13/12/202322:06EDGAR2Form 8-K - Current report
13/12/202322:05BWVir Biotechnology Announces Strategic Steps to Reduce..
06/12/202322:05BWVir Biotechnology to Present at J.P. Morgan 2024 42nd Annual..
13/11/202314:00BWVir Biotechnology to Present New Data from Its Ongoing Phase..
10/11/202314:00BWVir Biotechnology to Present Late-Breaking Data from Its..
08/11/202314:05BWVir Biotechnology Ranked the Fastest-Growing Company in..
03/11/202321:37EDGAR2Form 8-K - Current report
03/11/202321:33EDGAR2Form S-3ASR - Automatic shelf registration statement of..
03/11/202321:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:09EDGAR2Form 8-K - Current report
02/11/202321:05BWVir Biotechnology Provides Corporate Update and Reports..
30/10/202313:00BWVir Biotechnology Appoints Jennifer Towne, Ph.D., as..
12/10/202322:05GLOBEVir Biotechnology to Participate in the H.C. Wainwright 4th..
11/10/202314:00GLOBEVir Biotechnology Announces Multiple Abstracts Highlighting..
05/10/202322:30GLOBEVir Biotechnology to Provide Business Update and Report..
03/10/202314:01EDGAR2Form 8-K - Current report
03/10/202313:59GLOBEVir Biotechnology Awarded BARDA Funding to Support..
20/9/202314:00GLOBEVir Biotechnology Announces First Participant Dosed in New..
Apertura: 10,57 Min: 10,38 Max: 11,26
Chiusura: 10,27

La tua Cronologia

NASDAQ
VIR
Vir Biotechnology
NYSE
NRS
TSXV
GIR
AQSE
ROAD.GB
Roadside Real Estate
TSXV
GTI
BIT
I10105
IT0005590150 20240621 30...
AQSE
HMJD.GB
Hsbc Msci Japan Etf
COIN
FOXTEUR
Fox Trading
COIN
NYXGBP
NYX COIN
BOV
A1VB34Q
Avalonbay Communities
BIT
UC4AX9
Unicredit Bank
POLO
TRXBTC
TRON
LSE
0A87
Takeda Pharmaceutical
DGFX
NINOUSDT
Ninneko Token
LSE
BO53
Citi Fun 27
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network